HEADER VIRAL PROTEIN 05-MAY-24 9BOO TITLE CRYSTAL STRUCTURE OF MERS-COV NSP5 IN COMPLEX WITH PF-07817883 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE NSP5; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 3248-3553; COMPND 5 SYNONYM: 3CL-PRO,3CLP,NSP5; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MIDDLE EAST RESPIRATORY SYNDROME-RELATED SOURCE 3 CORONAVIRUS; SOURCE 4 ORGANISM_TAXID: 1335626; SOURCE 5 GENE: 1A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS PF-07817883, NSP5, MAIN PROTEASE, MERS-COV, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR P.CHEN,E.ARUTYUNOVA,M.J.LEMIEUX REVDAT 1 07-AUG-24 9BOO 0 JRNL AUTH P.CHEN,T.J.VAN OERS,E.ARUTYUNOVA,C.FISCHER,C.WANG,T.LAMER, JRNL AUTH 2 M.J.VAN BELKUM,H.S.YOUNG,J.C.VEDERAS,M.J.LEMIEUX JRNL TITL A STRUCTURAL COMPARISON OF ORAL SARS-COV-2 DRUG CANDIDATE JRNL TITL 2 IBUZATRELVIR COMPLEXED WITH THE MAIN PROTEASE (MPRO) OF JRNL TITL 3 SARS-COV-2 AND MERS-COV JRNL REF JACS AU 2024 JRNL REFN ESSN 2691-3704 JRNL DOI 10.1021/JACSAU.4C00508 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20.1_4487: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.42 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 42374 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.090 REMARK 3 FREE R VALUE TEST SET COUNT : 2157 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.4200 - 3.6900 0.98 2765 150 0.1426 0.1601 REMARK 3 2 3.6900 - 2.9300 0.99 2724 161 0.1619 0.1729 REMARK 3 3 2.9300 - 2.5600 0.99 2685 167 0.1915 0.1950 REMARK 3 4 2.5600 - 2.3300 0.97 2643 151 0.1946 0.1911 REMARK 3 5 2.3300 - 2.1600 0.99 2696 151 0.1883 0.2084 REMARK 3 6 2.1600 - 2.0300 0.99 2681 133 0.1878 0.2361 REMARK 3 7 2.0300 - 1.9300 0.99 2759 117 0.1994 0.2257 REMARK 3 8 1.9300 - 1.8500 0.99 2693 138 0.2008 0.2743 REMARK 3 9 1.8500 - 1.7800 0.98 2658 164 0.2020 0.2492 REMARK 3 10 1.7800 - 1.7200 0.97 2621 132 0.2050 0.2715 REMARK 3 11 1.7200 - 1.6600 0.99 2679 141 0.2060 0.2192 REMARK 3 12 1.6600 - 1.6100 0.99 2693 149 0.2128 0.2625 REMARK 3 13 1.6100 - 1.5700 0.99 2660 134 0.2062 0.2309 REMARK 3 14 1.5700 - 1.5300 0.99 2724 128 0.2303 0.2776 REMARK 3 15 1.5300 - 1.5000 0.94 2536 141 0.2585 0.2877 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.830 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2482 REMARK 3 ANGLE : 0.854 3400 REMARK 3 CHIRALITY : 0.072 388 REMARK 3 PLANARITY : 0.008 432 REMARK 3 DIHEDRAL : 7.878 352 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9BOO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAY-24. REMARK 100 THE DEPOSITION ID IS D_1000283795. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-APR-24 REMARK 200 TEMPERATURE (KELVIN) : 93.15 REMARK 200 PH : 7.0-8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50570 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 30.425 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 59.6 REMARK 200 DATA REDUNDANCY : 13.70 REMARK 200 R MERGE (I) : 0.02500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.60300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: CUBIC CRYSTALS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MAGNESIUM CHLORIDE HEXAHYDRATE, REMARK 280 0.1 M HEPES 7.0, 20 % W/V PEG 6000, PH 7.0, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 52.57650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.70000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 52.57650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.70000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -19.14739 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 45.10842 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 706 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 305 REMARK 465 GLN A 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH11 ARG A 79 O HOH A 503 1.59 REMARK 500 OD2 ASP A 33 O HOH A 501 2.01 REMARK 500 O HOH A 702 O HOH A 727 2.01 REMARK 500 OG1 THR A 274 O HOH A 502 2.06 REMARK 500 O HOH A 501 O HOH A 694 2.07 REMARK 500 NH1 ARG A 79 O HOH A 503 2.07 REMARK 500 OD1 ASP A 295 O HOH A 504 2.10 REMARK 500 O GLN A 271 O HOH A 502 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 503 O HOH A 552 4455 1.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 27 -168.80 -163.50 REMARK 500 ASP A 33 -128.85 54.06 REMARK 500 ASP A 51 74.69 -150.99 REMARK 500 ALA A 76 150.06 178.04 REMARK 500 ALA A 220 24.69 -140.70 REMARK 500 REMARK 500 REMARK: NULL DBREF 9BOO A 1 306 UNP K9N638 R1A_MERS1 3248 3553 SEQRES 1 A 306 SER GLY LEU VAL LYS MET SER HIS PRO SER GLY ASP VAL SEQRES 2 A 306 GLU ALA CYS MET VAL GLN VAL THR CYS GLY SER MET THR SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASN THR VAL TRP CYS PRO SEQRES 4 A 306 ARG HIS VAL MET CYS PRO ALA ASP GLN LEU SER ASP PRO SEQRES 5 A 306 ASN TYR ASP ALA LEU LEU ILE SER MET THR ASN HIS SER SEQRES 6 A 306 PHE SER VAL GLN LYS HIS ILE GLY ALA PRO ALA ASN LEU SEQRES 7 A 306 ARG VAL VAL GLY HIS ALA MET GLN GLY THR LEU LEU LYS SEQRES 8 A 306 LEU THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR SEQRES 9 A 306 THR PHE THR THR VAL LYS PRO GLY ALA ALA PHE SER VAL SEQRES 10 A 306 LEU ALA CYS TYR ASN GLY ARG PRO THR GLY THR PHE THR SEQRES 11 A 306 VAL VAL MET ARG PRO ASN TYR THR ILE LYS GLY SER PHE SEQRES 12 A 306 LEU CYS GLY SER CYS GLY SER VAL GLY TYR THR LYS GLU SEQRES 13 A 306 GLY SER VAL ILE ASN PHE CYS TYR MET HIS GLN MET GLU SEQRES 14 A 306 LEU ALA ASN GLY THR HIS THR GLY SER ALA PHE ASP GLY SEQRES 15 A 306 THR MET TYR GLY ALA PHE MET ASP LYS GLN VAL HIS GLN SEQRES 16 A 306 VAL GLN LEU THR ASP LYS TYR CYS SER VAL ASN VAL VAL SEQRES 17 A 306 ALA TRP LEU TYR ALA ALA ILE LEU ASN GLY CYS ALA TRP SEQRES 18 A 306 PHE VAL LYS PRO ASN ARG THR SER VAL VAL SER PHE ASN SEQRES 19 A 306 GLU TRP ALA LEU ALA ASN GLN PHE THR GLU PHE VAL GLY SEQRES 20 A 306 THR GLN SER VAL ASP MET LEU ALA VAL LYS THR GLY VAL SEQRES 21 A 306 ALA ILE GLU GLN LEU LEU TYR ALA ILE GLN GLN LEU TYR SEQRES 22 A 306 THR GLY PHE GLN GLY LYS GLN ILE LEU GLY SER THR MET SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO GLU ASP VAL ASN MET GLN SEQRES 24 A 306 ILE MET GLY VAL VAL MET GLN HET YDL A 401 65 HETNAM YDL N-(METHOXYCARBONYL)-3-METHYL-L-VALYL-(4R)-N-{(1Z,2S)-1- HETNAM 2 YDL IMINO-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPAN-2-YL}-4- HETNAM 3 YDL (TRIFLUOROMETHYL)-L-PROLINAMIDE HETSYN YDL IBUZATRELVIR, BOUND FORM; N-(METHOXYCARBONYL)-3-METHYL- HETSYN 2 YDL L-VALYL-(4R)-N-{(1S)-1-CYANO-2-[(3S)-2-OXOPYRROLIDIN- HETSYN 3 YDL 3-YL]ETHYL}-4-(TRIFLUOROMETHYL)-L-PROLINAMIDE, BOUND HETSYN 4 YDL FORM FORMUL 2 YDL C21 H32 F3 N5 O5 FORMUL 3 HOH *238(H2 O) HELIX 1 AA1 SER A 10 ALA A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 PRO A 45 LEU A 49 5 5 HELIX 4 AA4 ASN A 53 SER A 60 1 8 HELIX 5 AA5 MET A 61 HIS A 64 5 4 HELIX 6 AA6 MET A 184 PHE A 188 5 5 HELIX 7 AA7 CYS A 203 ASN A 217 1 15 HELIX 8 AA8 SER A 229 ALA A 239 1 11 HELIX 9 AA9 THR A 248 GLY A 259 1 12 HELIX 10 AB1 ALA A 261 TYR A 273 1 13 HELIX 11 AB2 THR A 292 GLY A 302 1 11 SHEET 1 AA1 7 ALA A 76 LEU A 78 0 SHEET 2 AA1 7 PHE A 66 LYS A 70 -1 N LYS A 70 O ALA A 76 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 MET A 25 LEU A 32 -1 O MET A 25 N CYS A 22 SHEET 5 AA1 7 THR A 35 PRO A 39 -1 O THR A 35 N LEU A 32 SHEET 6 AA1 7 LEU A 89 VAL A 94 -1 O LEU A 90 N CYS A 38 SHEET 7 AA1 7 VAL A 80 GLN A 86 -1 N VAL A 81 O THR A 93 SHEET 1 AA2 5 TYR A 104 PHE A 106 0 SHEET 2 AA2 5 VAL A 159 ALA A 171 1 O PHE A 162 N THR A 105 SHEET 3 AA2 5 VAL A 151 GLU A 156 -1 N THR A 154 O ASN A 161 SHEET 4 AA2 5 ALA A 114 TYR A 121 -1 N LEU A 118 O VAL A 151 SHEET 5 AA2 5 ARG A 124 VAL A 132 -1 O PHE A 129 N VAL A 117 SHEET 1 AA3 3 TYR A 104 PHE A 106 0 SHEET 2 AA3 3 VAL A 159 ALA A 171 1 O PHE A 162 N THR A 105 SHEET 3 AA3 3 THR A 174 SER A 178 -1 O SER A 178 N MET A 165 LINK SG CYS A 148 C2 YDL A 401 1555 1555 1.77 CRYST1 105.153 57.400 49.004 90.00 113.00 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009510 0.000000 0.004037 0.00000 SCALE2 0.000000 0.017422 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022169 0.00000